<?xml version="1.0" encoding="UTF-8"?>
<p>Researches indicated that appropriate use of low‐dose corticosteroids may be beneficial for the survival of severe COVID‐19 patients; however, it should strictly comply with the guidelines for recommended COVID‐19 patients, such as patients with refractory ARDS, sepsis or septic shock.
 <xref rid="jcmm15364-bib-0091" ref-type="ref">
  <sup>91</sup>
 </xref>, 
 <xref rid="jcmm15364-bib-0092" ref-type="ref">
  <sup>92</sup>
 </xref> Based on benevolent AI's proprietary artificial intelligence (AI)‐derived knowledge graph, baricitinib could also abate SARS‐CoV‐2 virus infectivity, virus replication and abnormal host inflammatory response in combination with direct antiviral drugs (lopinavir or ritonavir and remdesivir). This approach could facilitate the subsequent development of anti‐SARS‐CoV‐2 agents.
 <xref rid="jcmm15364-bib-0093" ref-type="ref">
  <sup>93</sup>
 </xref> The mechanism of Chinese herbal medicines against COVID‐19 may include the following process, such as antiviral, immune/inflammatory, hypoxic reactions and so on, and it may also directly inhibit the SARS‐CoV‐2.
 <xref rid="jcmm15364-bib-0094" ref-type="ref">
  <sup>94</sup>
 </xref>
</p>
